Evidence map›Paper›PMID 38907026›Full record

ArticleBone marrow transplantation2024

Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT.

Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, Vijaya Raj Bhatt, Josu de la Fuente, Aloysius Ho, Leslie Kean, Jong Wook Lee, Isabel Sánchez-Ortega, Bipin N Savani and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Anna SuredaClinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain. asureda@iconcologia.net.ORCID http://orcid.org/0000-0002-1238-6970
Paul A CarpenterClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Andrea BacigalupoFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Vijaya Raj BhattFred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.ORCID http://orcid.org/0000-0003-2513-0533
Josu de la FuenteDepartment of Paediatrics, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.ORCID http://orcid.org/0000-0002-0974-1249
Aloysius HoDepartment of Haematology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore.
Leslie KeanStem Cell Transplantation Program. Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0475-3926
Jong Wook LeeDivision of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-2949-4166
Isabel Sánchez-OrtegaEBMT Medical officer, EBMT executive office, Barcelona, Spain.ORCID http://orcid.org/0009-0005-5519-9154
Bipin N SavaniDivision of Hematology/ Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-3304-9965
Johannes ScheteligMedical Department I, University Hospital Carl Gustav Carus. TU Dresden & DKMS Group, Clinical Trials Unit, Dresden, Germany.ORCID http://orcid.org/0000-0002-2780-2981
Edward A StadtmauerPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Yoshiyuki TakahashiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.ORCID http://orcid.org/0000-0003-4404-2870
John KorethDepartment of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Nicolaus KrögerDepartment for Stem Cell Transplantation, University Medical Center Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5103-9966
Per LjungmanDepartment. of Cellular Therapy and Allogeneic Stem Cell Transplantation. Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8281-3245
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Uday PopatDepartment of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-7592-2224
Robert SoifferDepartment of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5810-1192
Heather E StefanskiCenter for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
Mohamed A Kharfan-DabajaDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0001-7394-5185

Funding

Single Cell and ImmunogenomicsP01CA229092 · NCI · DANA-FARBER CANCER INST · PI SOIFFER, ROBERT JON · 2019 to 2023
$13.8M
NCI NIH HHS P01 CA229092
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38907026
PMCPMC11368801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.